The interaction between RNF144A and PD-L1 highlights the therapeutic significance of targeting RNF144A in cancer treatment, particularly in bladder cancer, where PD-L1 plays a crucial role in immune evasion. The gene discussed is CD274; the disease is urinary bladder carcinoma.